These emerging therapies, including Wegovy, a similar compound, and Retatrutide , represent a significant advancement in managing type 2 diabetes and supporting weight management. They work by imitating the body’s natural incretin GLP-1 , assisting to regulate blood levels and lower appetite . The drug has somewhat different properties and may be